Background: SARS CoV-2 has globally affected more than 31 hundred thousand population with more than 2 hundred thousand deaths till date, since its inception from Wuhan, China in December 2019. World is still clueless regarding definitive treatment for this highly contagious disease. Till then we have to rely on time tested methods to delay/stop transmission of this viral disease by observing social isolation, hand hygiene and wearing face mask. Objective: The main objective of this review paper is to focus on different modes of transmission of this virus, comparison of this virus with previous similar analogy viral diseases like SARS and MERS and different strategies that can be planned or are ongoing to reduce/delay transmission of this virus in community contacts, especially in context to India. Methods: PUBMED, Google Scholar and BioRxiv search was performed with keywords; COVID- 19, mode of transmission, infection, India, BCG. Around 538 eligible papers were evaluated from time period of January 1 to 29 April 2020 and results were summarized Results: On analysis of different papers on mode of transmission it was found that this virus is highly contagious and spreads through air droplet, close contact, through fomites and different metallic surfaces and through aerosol in surroundings with high aerosol generating procedures only. Also, it can spread both in asymptomatic and symptomatic phase equally so early testing is essential. Also, it is mutating in different host environments so it is imperative to include different strains in vaccine preparation. Conclusion: Results demonstrate the fact that early screening, social distancing, isolation of symptomatic patients, respiratory etiquette are the main armaments presently to deal with this virus till effective treatment or vaccine becomes available in the near future. Furthermore, we would like to suggest the Indian government to create a National Viral Disease Management Board on lines of National Tuberculosis Elimination program to prevent and control such viral outbreaks in future.
Coronavirus disease 2019 (abbreviated “COVID-19”) is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The cases of COVID-19 infection since then were showing increasing trend in all over the world. The aim: to study the epidemiological distribution and determinants of COVID-19 pandemic. Methods: it is a descriptive study carried out at a tertiary care hospital of India. The population comprised of patients admitted in the hospital. Sample size comprised of all the subjects admitted in the hospital with established COVID 19 +ve cases. The duration of study was April 2020 to June 2020. The study was approved by the Institutional Ethical committee and Informed consent was obtained from each subject before the conduct of the study. Data collection was done by a pre-structured questionnaire. Data entry and analysis was done using SPSS version 20 software. Results: out of total 38 COVID-19 +ve cases, 95 % were male and 5 % female ant the maximum numbers of cases ranges between 36–40 years of age group with the median age of 32 years.53 % of cases were Muslim and 47 % Hindu by religion. The median duration of stay in hospital of all COVID-19 +ve cases was11 day that on further differentiation with co-morbidity was 15 days and 11.5 without any co-morbidity. The median duration taken between 1st sample taken and report provided was 2 days, between 2nd sample taken and report provided 1 day and between 1st and 2nd sample taken was 11 days. Conclusions: present study concluded that middle age persons were affected in majority which may be due to more exposure to public places. Co-morbidities are strong predictors of requirement for admission and duration of stay at hospital
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.